Dymon Asia Capital (Singapore) Pte. Ltd. Pfizer Inc Transaction History
Dymon Asia Capital (Singapore) Pte. Ltd.
- $416 Million
- Q4 2024
A detailed history of Dymon Asia Capital (Singapore) Pte. Ltd. transactions in Pfizer Inc stock. As of the latest transaction made, Dymon Asia Capital (Singapore) Pte. Ltd. holds 31,600 shares of PFE stock, worth $826,024. This represents 0.2% of its overall portfolio holdings.
Number of Shares
31,600
Previous 50,000
36.8%
Holding current value
$826,024
Previous $1.45 Million
42.09%
% of portfolio
0.2%
Previous 0.38%
Shares
2 transactions
Others Institutions Holding PFE
# of Institutions
3,377Shares Held
3.55BCall Options Held
106MPut Options Held
123M-
Vanguard Group Inc Valley Forge, PA519MShares$13.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.1 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.59 Billion0.31% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA155MShares$4.06 Billion0.78% of portfolio
-
Geode Capital Management, LLC Boston, MA121MShares$3.15 Billion0.25% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $147B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...